Coherus Biosciences reported $259.49M in Cash and Equivalent for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 304.49M 21.54M
Aerie Pharmaceuticals AERI:US $ 122.7M 28.88M
Akebia Therapeutics AKBA:US $ 252.76M 24.07M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
ALKERMES ALKS:US $ 258.34M 53.31M
Alnylam Pharmaceuticals ALNY:US $ 379.54M 117.04M
Amarin AMRN:US $ 290.99M 104.03M
Amgen AMGN:US $ 6112M 154M
Baxter International BAX:US $ 3182M 548M
Biogen BIIB:US $ 1742M 524.5M
Biomarin Pharmaceutical BMRN:US $ 641.53M 25.78M
Bluebird Bio BLUE:US $ 439.71M 122.01M
Bristol Myers Squibb BMY:US $ 11024M 42M
Coherus Biosciences CHRS:US $ 259.49M 281.67M
Eli Lilly And LLY:US $ 3002.4M 654.7M
Endo International Ordinary Shares ENDP:US $ 1427.78M 214.34M
Fujifilm 4901:JP Y 394795M 99972M
Gilead Sciences GILD:US $ 4065M 1932M
Horizon Pharma HZNP:US $ 811.61M 1268.3M
Ironwood Pharmaceuticals IRWD:US $ 438.47M 75.9M
LG Chem 051910:KS KW 2161860M 1112390M
Merk MRK:US $ 6981M 1081M
Myriad Genetics MYGN:US $ 117M 1.3M
Pacira Pharmaceuticals PCRX:US $ 66.7M 33.26M
Perrigo Ordinary Shares PRGO:US $ 470.9M 170.6M
Ptc Therapeutics PTCT:US $ 146.63M 62.18M
Regeneron Pharmaceuticals REGN:US $ 1437.9M 755.8M
Revance Therapeutics RVNC:US $ 249.43M 84.13M
Sarepta Therapeutics SRPT:US $ 1481.84M 20.81M
Teva Pharmaceutical TEVA:IT 2.44B 693M
Vertex Pharmaceuticals VRTX:US $ 6304.33M 316.14M
Xencor XNCR:US $ 176.96M 13.42M
Zoetis ZTS:US $ 3600M 2M